Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Syndax Pharmaceuticals Inc (SNDX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/02/2023 |
8-K
| Quarterly results |
| 08/03/2023 |
8-K
| Quarterly results |
| 07/24/2023 |
8-K
| Quarterly results |
| 05/26/2023 |
8-K
| Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits Interactive ... |
| 05/08/2023 |
8-K
| Quarterly results |
| 03/30/2023 |
8-K
| Quarterly results |
| 02/28/2023 |
8-K
| Quarterly results |
| 02/08/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...|
Docs:
|
"SYNDAX PHARMACEUTICALS, INC. 2023 INDUCEMENT PLAN Syndax Pharmaceuticals, Inc., a Delaware corporation , sets forth herein the terms of its 2023 Inducement Plan , as follows: 1. GENERAL 1.1 Purpose. This Plan is intended to provide an inducement material for certain individuals to enter into employment with the Company within the meaning of Rule 5635 of the NASDAQ Marketplace Rules, and incentives to Eligible Employees to stimulate their efforts towards the success of the Company and to operate and manage its business in a manner that will provide for the long-term growth and profitability of the Company. To that end, the Plan provides for the grant of Awards of Options, Stock Appreciation Rights, Restricted Stock, Unrestricted Stock, Stock Units, Dividend Equivalent Rights, Performance Aw...",
"Non-qualified Option This Agreement evidences an award of an Option exercisable for that number of shares of Stock set forth on the cover sheet and subject to the vesting and other conditions set forth in the Agreement and in the Plan. This Option is granted subject to the terms and conditions of the Plan as a material inducement to you entering into employment with the Company in compliance with NASDAQ Listing Rule 5634. This Option is not intended to be an incentive stock option under Section 422 of the Code and will be interpreted accordingly. Transfer of Option During your lifetime, only you may exercise the Option. The Option may not be sold, assigned, transferred, pledged, hypothecated or otherwise encumbered, whether by operation of law or otherwise, nor may the Option be made subje..." |
|
| 12/14/2022 |
8-K
| Quarterly results |
| 12/07/2022 |
8-K
| Quarterly results |
| 12/05/2022 |
8-K
| Quarterly results |
| 11/03/2022 |
8-K
| Quarterly results |
| 09/23/2022 |
8-K
| Termination of a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits ... |
| 08/08/2022 |
8-K
| Quarterly results |
| 06/13/2022 |
8-K
| Quarterly results |
| 05/11/2022 |
8-K
| Quarterly results |
| 05/09/2022 |
8-K
| Quarterly results |
| 03/01/2022 |
8-K
| Quarterly results |
| 02/24/2022 |
8-K
| Quarterly results |
| 02/03/2022 |
8-K
| Quarterly results |
| 12/23/2021 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 12/17/2021 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 12/13/2021 |
8-K
| Quarterly results |
| 12/09/2021 |
8-K
| Quarterly results |
| 11/15/2021 |
8-K
| Quarterly results |
| 10/04/2021 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 09/27/2021 |
8-K
| Quarterly results |
| 09/15/2021 |
8-K
| Quarterly results |
| 08/09/2021 |
8-K
| Quarterly results |
| 05/13/2021 |
8-K
| Quarterly results |
| 05/11/2021 |
8-K
| Quarterly results |
| 03/08/2021 |
8-K
| Quarterly results |
| 02/05/2021 |
8-K
| Quarterly results |
| 12/09/2020 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
|
|
|